Increased mortality after a first myocardial infarction in human immunodeficiency virus-infected patients; a nested cohort study.

Détails

Ressource 1Télécharger: BIB_E5C6BC3A4EDC.P001.pdf (466.04 [Ko])
Etat: Public
Version: de l'auteur⸱e
ID Serval
serval:BIB_E5C6BC3A4EDC
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Increased mortality after a first myocardial infarction in human immunodeficiency virus-infected patients; a nested cohort study.
Périodique
Aids Research and Therapy
Auteur⸱e⸱s
Carballo D., Delhumeau C., Carballo S., Bähler C., Radovanovic D., Hirschel B., Clerc O., Bernasconi E., Fasel D., Schmid P., Cusini A., Fehr J., Erne P., Keller P.F., Ledergerber B., Calmy A., AMIS registry
Collaborateur⸱rice⸱s
Swiss HIV Cohort Study
Contributeur⸱rice⸱s
AMIS registry
ISSN
1742-6405 (Electronic)
ISSN-L
1742-6405
Statut éditorial
Publié
Date de publication
2015
Volume
12
Numéro
3
Pages
4
Langue
anglais
Notes
Publication types: Journal Article
Résumé
AIMS: HIV infection may be associated with an increased recurrence rate of myocardial infarction. Our aim was to determine whether HIV infection is a risk factor for worse outcomes in patients with coronaray artery disease.
METHODS: We compared data aggregated from two ongoing cohorts: (i) the Acute Myocardial Infarction in Switzerland (AMIS) registry, which includes patients with acute myocardial infarction (AMI), and (ii) the Swiss HIV Cohort Study (SHCS), a prospective registry of HIV-positive (HIV+) patients. We included all patients who survived an incident AMI occurring on or after 1st January 2005. Our primary outcome measure was all-cause mortality at one year; secondary outcomes included AMI recurrence and cardiovascular-related hospitalisations. Comparisons used Cox and logistic regression analyses, respectively.
RESULTS: There were 133 HIV+, (SHCS) and 5,328 HIV-negative [HIV-] (AMIS) individuals with incident AMI. In the SHCS and AMIS registries, patients were predominantly male (72% and 85% male, respectively), with a median age of 51 years (interquartile range [IQR] 46-57) and 64 years (IQR 55-74), respectively. Nearly all (90%) of HIV+ individuals were on successful antiretroviral therapy. During the first year of follow-up, 5 (3.6%) HIV+ and 135 (2.5%) HIV- individuals died. At one year, HIV+ status after adjustment for age, sex, calendar year of AMI, smoking status, hypertension and diabetes was associated with a higher risk of death (HR 4.42, 95% CI 1.73-11.27). There were no significant differences in recurrent AMIs (4 [3.0%] HIV+ and 146 [3.0%] HIV- individuals, OR 1.16, 95% CI 0.41-3.27) or in hospitalization rates (OR 0.68 [95% CI 0.42-1.11]).
CONCLUSIONS: HIV infection was associated with a significantly increased risk of all-cause mortality one year after incident AMI.
Mots-clé
Agglutination Tests, Ampicillin/pharmacology, Animals, Epithelium/ultrastructure, Feeding Behavior, Rabbits, Tsetse Flies/microbiology, Tsetse Flies/ultrastructure
Pubmed
Web of science
Open Access
Oui
Création de la notice
22/02/2015 10:37
Dernière modification de la notice
20/08/2019 17:09
Données d'usage